News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Data on Neogenix Oncology, Inc.’s Phase I Study of Novel Therapeutic Antibody NPC-1C (Ensituximab) to be Presented at American Society of Clinical Oncology’s 2011 Annual Meeting


6/3/2011 8:10:00 AM

Neogenix Oncology announced today that researchers from Johns Hopkins University Hospital will be giving a poster presentation on the phase I study of ensituximab, a novel therapeutic antibody to treat pancreas and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting to be held June 3-7, 2011 at McCormick Place in Chicago, IL, USA.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES